BCM
AMGN icon

Bluefin Capital Management’s Amgen AMGN Stock Holding History

Bluefin Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,800
Closed -$85K – 609
2019
Q3 		$85K Buy
+14,800
New +$2.84M 0.01% 327
2018
Q4 		– Sell
-11,600
Closed -$36K – 419
2018
Q3 		$36K Buy
+11,600
New +$2.29M ﹤0.01% 409
2016
Q4 		– Sell
-9,700
Closed -$22K – 529
2016
Q3 		$22K Buy
+9,700
New +$1.64M ﹤0.01% 370

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bluefin Capital Management's AMGN Position: Q1 2026 in Review

Bluefin Capital Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 3,800 shares — an estimated $1.24M sold.

Bluefin Capital Management first reported a position in AMGN in Q2 2013 and held it in 22 quarters. The position peaked at $4.04M in Q4 2014. 3,132 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bluefin Capital Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Bluefin Capital Management sold 3,800 Amgen shares in Q1 2026, an estimated $1.24M.
  • Bluefin Capital Management first reported a position in Amgen in Q2 2013 and held it in 22 quarters.
  • Bluefin Capital Management's Amgen position peaked at $4.04M in Q4 2014.
  • 3,132 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bluefin Capital Management's 13F filing for Q1 2026, filed 15 May 2026.